These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8304980)

  • 1. Hypocholesterolemic properties of plant indoles. Inhibition of acyl-CoA:cholesterol acyltransferase activity and reduction of serum LDL/VLDL cholesterol levels by glucobrassicin derivatives.
    Dunn SE; LeBlanc GA
    Biochem Pharmacol; 1994 Jan; 47(2):359-64. PubMed ID: 8304980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the plant compound indole-3-carbinol on hepatic cholesterol homoeostasis.
    LeBlanc GA; Stuart JD; Dunn SE; Baldwin WS
    Food Chem Toxicol; 1994 Jul; 32(7):633-9. PubMed ID: 8045476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
    Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H
    Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
    Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
    Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Huff MW
    Biochim Biophys Acta; 1998 Jul; 1393(1):63-79. PubMed ID: 9714740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
    Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
    Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel indoline-based acyl-CoA:cholesterol acyltransferase inhibitor with antiperoxidative activity: improvement of physicochemical properties and biological activities by introduction of carboxylic acid.
    Takahashi K; Kasai M; Ohta M; Shoji Y; Kunishiro K; Kanda M; Kurahashi K; Shirahase H
    J Med Chem; 2008 Aug; 51(15):4823-33. PubMed ID: 18620381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
    Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
    Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT.
    Krause BR; Anderson M; Bisgaier CL; Bocan T; Bousley R; DeHart P; Essenburg A; Hamelehle K; Homan R; Kieft K
    J Lipid Res; 1993 Feb; 34(2):279-94. PubMed ID: 8429262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
    Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
    Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig.
    Bocan TM; Mueller SB; Uhlendorf PD; Brown EQ; Mazur MJ; Black AE
    Atherosclerosis; 1993 Mar; 99(2):175-86. PubMed ID: 8503946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low-density-lipoprotein receptor and on acyl-CoA:cholesterol acyltransferase activities in rat liver.
    Salter AM; Hayashi R; al-Seeni M; Brown NF; Bruce J; Sorensen O; Atkinson EA; Middleton B; Bleackley RC; Brindley DN
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):825-32. PubMed ID: 2064617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of acyl-Coa:cholesterol acyltransferase. 4. A novel series of urea ACAT inhibitors as potential hypocholesterolemic agents.
    Trivedi BK; Holmes A; Stoeber TL; Blankley CJ; Roark WH; Picard JA; Shaw MK; Essenburg AD; Stanfield RL; Krause BR
    J Med Chem; 1993 Oct; 36(22):3300-7. PubMed ID: 8230120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
    Schuler LA; Toaff ME; Strauss JF
    Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyl-coenzyme A: cholesterol- acyl-coenzyme A:1,2-diacylglycerol acyltransferase and phosphatidate phosphorylase activities in liver microsomes from nephrotic rats.
    Agbedana EO; Yamamoto T; Moriwaki Y; Takahashi S; Suda M; Higashino K
    Afr J Med Med Sci; 1996 Dec; 25(4):365-71. PubMed ID: 9532309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.
    Vaziri ND; Liang K
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1038-43. PubMed ID: 15280162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyl-CoA: cholesterol acyltransferase inhibitory activity of ginseng sapogenins, produced from the ginseng saponins.
    Kwon BM; Kim MK; Baek NI; Kim DS; Park JD; Kim YK; Lee HK; Kim SI
    Bioorg Med Chem Lett; 1999 May; 9(10):1375-8. PubMed ID: 10360739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of acyl-CoA:cholesterol O-acyltransferase. 1. Identification of acyl-CoA:cholesterol O-acyltransferase subtypes by differential diethyl pyrocarbonate sensitivity.
    Kinnunen PM; DeMichele A; Lange LG
    Biochemistry; 1988 Sep; 27(19):7344-50. PubMed ID: 3207680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.